Alcidion Group Ltd
Alcidion Group Limited is a healthcare technology company.
The business
Alcidion Group Limited is a healthcare technology company. Its principal activities include the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its strategic partners and the delivery of product implementation, product support and maintenance, systems integration, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its Miya Precision is a FHIR-event platform that facilitates multiple clinical and operational applications. Its solutions include patient flow, virtual care, operations center, specialized care, data & analytics, integrated care record, clinical workflow, and others. Smartpage is an advanced smartphone and Web-based system for hospital communication and task management, addressing the requirements of both clinical and non-clinical users.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news

Alcidion Group Reports Record Operating Cash Flow in June Quarter
Alcidion posts record June quarter cash flow of A$7.7m on A$24.6m receipts, incl. A$10.6m Sussex upfront; FY26 guidance: rev ~A$51.6m, EBITDA >A$5m.

Alcidion Expands Patient Flow Business with Kyra Acquisition from Telstra Health
Alcidion to acquire Telstra Health Kyra suite for $3m, boosting FY26 revenue to ~$3.7m and delivering earnings accretion by June 2026; debt-free with $15m cash.

Alcidion Registers Miya Precision’s Concept Detection Capability in Australia and UK
Alcidion wins dual Class I SaMD registrations for Miya Precision in Australia and UK, enabling regulated, AI-assisted clinical documentation.

Alcidion Named Preferred EPR Supplier for Over $35M UK Contract
Alcidion named preferred EPR supplier for UK NHS trust; potential >$35m over 7 years as Miya Precision deploys with UHSx starting Q4 FY26.
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.